Virtus LifeSci Biotech Pr... (BBP)
NYSEArca: BBP
· Echtzeitkurs · USD
101.09
-0.83 (-0.81%)
Zum Schluss: Aug 13, 2026, 3:59 PM
Virtus LifeSci Biotech Products ETF (BBP) ETF Price, Holdings & Analysis
-0.81% (1D)
| Geld | 0 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 98.54 Mio |
| NAV | 102.08 |
| Beta | 0.76 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | k.A. |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Dec 16, 2014 |
| Brief | 101.08 |
| Volumen | 7,675 |
| Ø Vol. (20D) | 8,698 |
| Eröffnung | 103.12 |
| Vortagesschluss | 101.92 |
| Tagesspanne | 100.89 - 103.39 |
| 52-Wk Range | 66.22 - 105.21 |
| Positionen | k.A. |
| Kostenquote | 0.34% |
Über BBP
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Anlageklasse Equity
Tickersymbol BBP
Auflagedatum Dec 16, 2014
Anbieter Virtus
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 19.61% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.34% |
| Kiniksa Pharmaceutic... | KNSA | 1.97% |
| Verastem Inc | VSTM | 1.95% |
| Precigen Inc | PGEN | 1.94% |
| Omeros Corp | OMER | 1.87% |
| Nuvation Bio Inc Ord... | NUVB | 1.77% |
| Regeneron Pharmaceut... | REGN | 1.72% |
| Protagonist Therapeu... | PTGX | 1.71% |
| Acadia Pharmaceutica... | ACAD | 1.69% |
| Bridgebio Pharma Inc | BBIO | 1.65% |
Dividenden Dividendenrendite 0.07%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 20, 2017 | $0.0720 | k.A. |
| Dec 21, 2015 | $0.3970 | k.A. |
